RANZCR: Workforce challenges face radiation oncology in New Zealand
August 4, 2022 -- A shortage of radiation oncologists may be looming in New Zealand, according to the results of a survey that are being presented at this week's New Zealand Annual Scientific Meeting 2022, hosted by the Royal Australian and New Zealand College of Radiologists (RANZCR). Read More
Radiopharm collaborates with Lantheus on theranostic agent
August 4, 2022 -- Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications. Read More
IBA signs collaboration on proton therapy
August 4, 2022 -- Proton therapy developer Ion Beam Applications (IBA) has signed a collaboration agreement on its ConformalFlash proton therapy technique with the Fred Hutchinson Cancer Center and the University of Washington, both in Seattle. Read More
ViewRay reports revenue spike for Q2
August 3, 2022 -- Image-guided radiation therapy vendor ViewRay reported a major increase in revenues for the second quarter of 2022. Read More
Shine submits drug master file for Lu-177
August 1, 2022 -- Medical isotope firm Shine Technologies has submitted a drug master file with the U.S. Food and Drug Administration for its non-carrier-added lutetium-177 (Lu-177) chloride radiopharmaceutical. Read More
NorthStar inks Ac-225 supply deal with Clovis
July 21, 2022 -- NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope. Read More
Clarity completes recruitment for prostate cancer trial
July 20, 2022 -- Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer. Read More
ViewRay receives order from Japanese university
July 19, 2022 -- Image-guided radiation therapy vendor ViewRay has secured an order for its MRIdian MRI-guided radiation therapy system from Saitama Medical University International Medical Center in Japan. Read More
ECR: Should patient radiation shielding stay or should it go?
July 18, 2022 -- European experts are gradually reaching a consensus that radiation shielding is no longer needed for some imaging exams, yet the idea may be a hard pill to swallow at some facilities. With that in mind, a panel discussion held at ECR 2022 in Vienna addressed the pros and cons of the issue. Read More
Accuray highlights data presented at ISRS 2022
July 13, 2022 -- Radiation therapy developer Accuray is highlighting research being presented at the International Stereotactic Radiosurgery Society (ISRS) meeting in Milan, Italy, that the company says demonstrates the value of its CyberKnife system for treating neurological indications. Read More
Special Feature
Representation in radiation oncology remains challenging

Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more